Differential sensitivity of Src-family kinases to activation by SH3 domain displacement

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Moroco, Jamie A ^a   Craigo, Jodi K ^a   Iacob, Roxana E ^b   Wales, Thomas E ^b   Engen, John R ^b   Smithgall, Thomas E ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NORTHEASTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMATOPOIETIC CELL KINASE; PROTEIN KINASE FYN; PROTEIN KINASE LYN; PROTEIN KINASE P60; PROTEIN SH3; PROTEIN TYROSINE KINASE; PEPTIDE;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; BINDING AFFINITY; CATALYSIS; DOWN REGULATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOLECULAR PROBE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SENSITIVITY ANALYSIS; SIGNAL TRANSDUCTION; CHEMISTRY; ENZYME ACTIVATION; GENETICS; METABOLISM; SRC HOMOLOGY DOMAIN;

ENZYME ACTIVATION; HUMANS; PEPTIDES; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; SRC-FAMILY KINASES;

EID: 84934447547     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0105629     Document Type: Article

References (44)

1. Parsons SJ, Parsons JT (2004) Src family kinases, key regulators of signal transduction. Oncogene 23: 7906-7909. (Pubitemid 39468849)
2. Thomas SM, Brugge JS (1997) Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 13: 513-609. (Pubitemid 28034534)
3. Yeatman TJ (2004) A renaissance for SRC. Nat Rev Cancer 4: 470-480.
4. Resh MD (1999) Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim Biophys Acta 1451: 1-16.
5. Boggon TJ, Eck MJ (2004) Structure and regulation of Src family kinases. Oncogene 23: 7918-7927. (Pubitemid 39468851)
6. Chong YP, Ia KK, Mulhern TD, Cheng HC (2005) Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases. Biochim Biophys Acta 1754: 210-220. (Pubitemid 41797700)
7. Schindler T, Sicheri F, Pico A, Gazit A, Levitzki A, et al. (1999) Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol Cell 3: 639-648. (Pubitemid 29268447)
8. Xu W, Doshi A, Lei M, Eck MJ, Harrison SC (1999) Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol Cell 3: 629-638. (Pubitemid 29268446)
9. Sicheri F, Moarefi I, Kuriyan J (1997) Crystal structure of the Src family tyrosine kinase Hck. Nature 385: 602-609. (Pubitemid 27087567)
10. Xu W, Harrison SC, Eck MJ (1997) Three-dimensional structure of the tyrosine kinase c-Src. Nature 385: 595-602. (Pubitemid 27087566)
11. Briggs SD, Smithgall TE (1999) SH2-kinase linker mutations release Hck tyrosine kinase and transforming activities in rat-2 fibroblasts. J Biol Chem 274: 26579-26583.
12. Brown MT, Cooper JA (1996) Regulation, substrates, and functions of Src. Biochim Biophys Acta 1287: 121-149.
13. Thomas JW, Ellis B, Boerner RJ, Knight WB, White GC, et al. (1998) SH2- and SH3-mediated interactions between focal adhesion kinase and Src. J Biol Chem 273: 577-583. (Pubitemid 28042247)
14. Moarefi I, LaFevre-Bernt M, Sicheri F, Huse M, Lee C-H, et al. (1997) Activation of the Src-family tyrosine kinase Hck by SH3 domain displacement. Nature 385: 650-653. (Pubitemid 27087580)
15. Briggs SD, Sharkey M, Stevenson M, Smithgall TE (1997) SH3-mediated Hck tyrosine kinase activation and fibroblast transformation by the Nef protein of HIV-1. J Biol Chem 272: 17899-17902. (Pubitemid 27306363)
16. Meyn MA, III, Smithgall TE (2009) Chemical genetics identifies c-Src as an activator of primitive ectoderm formation in murine embryonic stem cells. Sci Signal 2: ra64.
17. Anneren C, Cowan CA, Melton DA (2004) The Src family of tyrosine kinases is important for embryonic stem cell self-renewal. J Biol Chem 279: 31590-31598. (Pubitemid 39037828)
18. Zhang X, Meyn MA, III, Smithgall TE (2013) c-Yes Tyrosine Kinase Is a Potent Suppressor of ES Cell Differentiation and Antagonizes the Actions of Its Closest Phylogenetic Relative, c-Src. ACS Chem Biol 9: 139-146.
19. Sancier F, Dumont A, Sirvent A, Paquay de PL, Edmonds T, et al. (2011) Specific oncogenic activity of the Src-family tyrosine kinase c-Yes in colon carcinoma cells. PLoS One 6: e17237.
20. Rickles RJ, Botfield MC, Zhou XM, Henry PA, Brugge JS, et al. (1995) Phage display selection of ligand residues important for Src homology 3 domain binding specificity. Proc Natl Acad Sci U S A 92: 10909-10913.
21. Feng S, Kasahara C, Rickles RJ, Schreiber SL (1995) Specific interactions outside the proline-rich core of two classes of Src homology 3 ligands. Proc Natl Acad Sci U S A 92: 12408-12415. (Pubitemid 26014079)
22. Lerner EC, Trible RP, Schiavone AP, Hochrein JM, Engen JR, et al. (2005) Activation of the Src Family Kinase Hck without SH3-Linker Release. J Biol Chem 280: 40832-40837. (Pubitemid 41780575)
23. Trible RP, Emert-Sedlak L, Smithgall TE (2006) HIV-1 Nef selectively activates SRC family kinases HCK, LYN, and c-SRC through direct SH3 domain interaction. J Biol Chem 281: 27029-27038. (Pubitemid 44401731)
24. Boerner RJ, Barker SC, Knight WB (1995) Kinetic mechanisms of the forward and reverse pp60c-src tyrosine kinase reactions. Biochemistry 34: 16419-16423. (Pubitemid 26006487)
25. Barker SC, Kassel DB, Weigl D, Huang X, Luther MA, et al. (1995) Characterization of pp60c-src tyrosine kinase activities using a continuous assay: autoactivation of the enzyme is an intermolecular autophosphorylation process. Biochemistry 34: 14843-14851. (Pubitemid 3002541)
26. Knight ZA, Shokat KM (2005) Features of selective kinase inhibitors. Chem Biol 12: 621-637. (Pubitemid 43142039)
27. Rickles RJ, Botfield MC, Weng Z, Taylor JA, Green OM, et al. (1994) Identification of Src, Fyn, Lyn, PI3K and Abl SH3 domain ligands using phage display libraries. EMBO J 13: 5598-5604.
28. Porter M, Schindler T, Kuriyan J, Miller WT (2000) Reciprocal regulation of Hck activity by phosphorylation of Tyr(527) and Tyr(416). Effect of introducing a high affinity intramolecular SH2 ligand. J Biol Chem 275: 2721-2726. (Pubitemid 30082042)
29. Saksela K, Cheng G, Baltimore D (1995) Proline-rich (PxxP) motifs in HIV-1 Nef bind to SH3 domains of a subset of Src kinases and are required for the enhanced growth of Nef+ viruses but not for down-regulation of CD4. EMBO J 14: 484-491.
30. Briggs SD, Lerner EC, Smithgall TE (2000) Affinity of Src family kinase SH3 domains for HIV Nef in vitro does not predict kinase activation by Nef in vivo. Biochemistry: 489-495. (Pubitemid 30077622)
31. LaFevre-Bernt M, Sicheri F, Pico A, Porter M, Kuriyan J, et al. (1998) Intramolecular regulatory interactions in the Src family kinase Hck probed by mutagenesis of a conserved tryptophan residue. Journal of Biological Chemistry 273: 32129-32134. (Pubitemid 29177157)
32. Hantschel O, Superti-Furga G (2004) Regulation of the c-Abl and Bcr-Abl tyrosine kinases. Nat Rev Mol Cell Biol 5: 33-44. (Pubitemid 38089839)
33. Panjarian S, Iacob RE, Chen S, Wales TE, Engen JR, et al. (2013) Enhanced SH3/linker interaction overcomes Abl kinase activation by gatekeeper and myristic acid binding pocket mutations and increases sensitivity to small molecule inhibitors. J Biol Chem 288: 6116-6129.
34. Mitra SK, Schlaepfer DD (2006) Integrin-regulated FAK-Src signaling in normal and cancer cells. Curr Opin Cell Biol 18: 516-523. (Pubitemid 44332916)
35. Wang AV, Scholl PR, Geha RS (1994) Physical and functional association of the high-affinity immunoglobulin G receptor (Fc gamma RI) with the kinases Hck and Lyn. J Exp Med 180: 1165-1170. (Pubitemid 24256631)
36. Kedzierska K, Vardaxis NJ, Jaworowski A, Crowe SM (2001) FcgammaR-mediated phagocytosis by human macrophages involves Hck, Syk, and Pyk2 and is augmented by GM-CSF. J Leukoc Biol 70: 322-328. (Pubitemid 32751525)
37. Durden DL, Kim HM, Calore B, Liu Y (1995) The Fc gamma RI receptor signals through the activation of Hck and MAP kinase. J Immunol 154: 4039-4047.
38. Bhattacharjee A, Pal S, Feldman GM, Cathcart MK (2011) Hck is a key regulator of gene expression in alternatively activated human monocytes. J Biol Chem 286: 36709-36723.
39. Seeliger MA, Young M, Henderson MN, Pellicena P, King DS, et al. (2005) High yield bacterial expression of active c-Abl and c-Src tyrosine kinases. Protein Sci 14: 3135-3139. (Pubitemid 41770154)
40. Iacob RE, Pene-Dumitrescu T, Zhang J, Gray NS, Smithgall TE, et al. (2009) Conformational disturbance in Abl kinase upon mutation and deregulation. Proc Natl Acad Sci U S A 106: 1386-1391.
41. Charter NW, Kauffman L, Singh R, Eglen RM (2006) A generic, homogenous method for measuring kinase and inhibitor activity via adenosine 59-diphosphate accumulation. J Biomol Screen 11: 390-399. (Pubitemid 43846339)
42. Lam KS, Wu J, Lou Q (1995) Identification and characterization of a novel synthetic peptide substrate specific for Src-family protein tyrosine kinases. Int J Pept Protein Res 45: 587-592.
43. Boerner RJ, Kassel DB, Barker SC, Ellis B, DeLacy P, et al. (1996) Correlation of the phosphorylation states of pp60c-src with tyrosine kinase activity: the intramolecular pY530-SH2 complex retains significant activity if Y419 is phosphorylated. Biochemistry 35: 9519-9525. (Pubitemid 26320059)
44. Plumb RS, Johnson KA, Rainville P, Smith BW, Wilson ID, et al. (2006) UPLC/MS(E); a new approach for generating molecular fragment information for biomarker structure elucidation. Rapid Commun Mass Spectrom 20: 1989-1994. (Pubitemid 44024575)